I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| epithelial cell | 5 studies | 27% ± 9% | |
| endothelial cell | 4 studies | 20% ± 3% | |
| B cell | 3 studies | 20% ± 3% | |
| classical monocyte | 3 studies | 21% ± 3% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| epithelial cell | 5 studies | 27% ± 9% | |
| endothelial cell | 4 studies | 20% ± 3% | |
| B cell | 3 studies | 20% ± 3% | |
| classical monocyte | 3 studies | 21% ± 3% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| peripheral blood | 3 studies | 20% ± 1% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| bladder | 100% | 1028.29 | 21 / 21 | 100% | 14.96 | 504 / 504 |
| esophagus | 100% | 940.36 | 1445 / 1445 | 100% | 18.33 | 183 / 183 |
| kidney | 100% | 907.67 | 89 / 89 | 100% | 27.76 | 901 / 901 |
| prostate | 100% | 955.62 | 245 / 245 | 100% | 18.27 | 502 / 502 |
| thymus | 100% | 1308.33 | 653 / 653 | 100% | 27.40 | 605 / 605 |
| breast | 100% | 1071.55 | 459 / 459 | 100% | 15.20 | 1117 / 1118 |
| intestine | 100% | 970.07 | 966 / 966 | 100% | 16.70 | 526 / 527 |
| lung | 100% | 1103.68 | 577 / 578 | 100% | 15.96 | 1154 / 1155 |
| stomach | 100% | 871.48 | 359 / 359 | 100% | 15.92 | 285 / 286 |
| pancreas | 100% | 622.32 | 328 / 328 | 99% | 15.58 | 177 / 178 |
| skin | 100% | 1142.38 | 1809 / 1809 | 99% | 15.44 | 469 / 472 |
| ovary | 100% | 1104.92 | 180 / 180 | 99% | 10.12 | 426 / 430 |
| uterus | 100% | 884.89 | 170 / 170 | 99% | 14.27 | 454 / 459 |
| adrenal gland | 100% | 853.97 | 258 / 258 | 97% | 11.85 | 222 / 230 |
| brain | 95% | 418.29 | 2515 / 2642 | 100% | 17.18 | 704 / 705 |
| liver | 100% | 822.22 | 226 / 226 | 87% | 7.45 | 355 / 406 |
| adipose | 100% | 1097.13 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 1075.29 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 16.01 | 29 / 29 |
| spleen | 100% | 1180.58 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 14.94 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 16.14 | 1 / 1 |
| peripheral blood | 98% | 962.21 | 907 / 929 | 0% | 0 | 0 / 0 |
| heart | 98% | 718.03 | 840 / 861 | 0% | 0 | 0 / 0 |
| muscle | 96% | 351.35 | 767 / 803 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 94% | 8.89 | 75 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0016567 | Biological process | protein ubiquitination |
| GO_0008150 | Biological process | biological_process |
| GO_0005575 | Cellular component | cellular_component |
| GO_0097602 | Molecular function | cullin family protein binding |
| GO_0005515 | Molecular function | protein binding |
| Gene name | KLHL36 |
| Protein name | Kelch-like protein 36 Kelch like family member 36 |
| Synonyms | C16orf44 |
| Description | FUNCTION: Probable substrate-specific adapter of an E3 ubiquitin-protein ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins. . |
| Accessions | Q8N4N3 H3BQW5 ENST00000564996.6 [Q8N4N3-1] ENST00000258157.9 [Q8N4N3-2] H3BQE9 ENST00000565743.1 ENST00000569472.5 ENST00000567410.5 H3BPB9 |
